ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Property, Plant & Equipment (Net) history
Currency unavailable · from the balance sheet
No Property, Plant & Equipment (Net) data reported for this period type.
Property, Plant & Equipment (Net) vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $142.15M USD | -5.4% | +44.6% | 48.2% | |
| Mar 2026 | $137.53M USD | +3.0% | -2.7% | 56.2% | |
| Mar 2026 | $26.5M USD | -23.4% | -14.8% | 10.8% | |
| Mar 2026 | $18.07M USD | -30.9% | -23.4% | 3.1% | |
| Mar 2026 | €12.06M EUR | -17.9% | -8.1% | 12.2% | |
| Mar 2026 | $6.38M USD | — | — | 2.2% | |
| Mar 2026 | $5.89M USD | -20.9% | -18.2% | 1.3% | |
| Mar 2026 | $1.54M USD | -14.6% | -7.4% | 1.3% | |
| Mar 2026 | $916K USD | -17.4% | -0.1% | 0.5% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -17.7% | -7.7% | 3.1% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.